Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    18282805 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: Capecitabine/cisplatin;   Drug: S-1/cisplatin;   Drug: Capecitabine/oxaliplatin;   Drug: 5-fluorouracil/oxaliplatin;   Drug: Capecitabine;   Drug: S-1;   Drug: 5-fluorouracil
2 Completed S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: S-1;   Drug: Cisplatin;   Drug: Oxaliplatin
3 Completed Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
Condition: Gastric Cancer
Interventions: Drug: TS-1 and cisplatin;   Drug: TS-1

Indicates status has not been verified in more than two years